Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: A scientific statement from the American heart association

Authors

Barbara S. Wiggins, Medical University of South Carolina, United States
Joseph J. Saseen, University of Colorado Anschutz Medical Campus, United States
Robert L. PageII, University of Colorado Skaggs, United States
Brent N. Reed, University of Maryland School of Pharmacy, United States
Kevin Sneed, University of South Florida, United States
John B. Kostis, Rutgers Robert Wood Johnson Medical School, United States
David Lanfear, Henry Ford Hospital, United States
Salim S. Virani, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, United StatesFollow
Pamela B. Morris, Medical University of South Carolina, United States

Document Type

Article

Department

Cardiology

Comments

Abstract is not provided by the author/publisher. This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Circulation

Recommended Citation

Wiggins, B. S., Saseen, J. J., PageII, R. L., Reed, B. N., Sneed, K., Kostis, J. B., Lanfear, D., Virani, S. S., Morris, P. B. (2016). Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: A scientific statement from the American heart association. Circulation, 134(21), e468-e495.
Available at: https://ecommons.aku.edu/provost_office/81